FDA Sets March 28 Date To Discuss Newly Published Draft User Fee Pact
This article was originally published in The Gray Sheet
Executive Summary
The agency published its draft commitment letter and draft legislative language for user fee reauthorization March 15. A public meeting is set for the end of the month, and public comments will be accepted through April 16.
You may also be interested in...
CDRH Extends Device Establishment Registration Deadline
The device center has extended the annual medical device registration period by one month to Jan. 31, as companies and FDA adopt new registration and registration fee requirements established in the FDA Safety and Innovation Act and recent regulatory revisions.
Patient, Consumer Groups Decry Lack Of User Fee Funding For Post-Market Surveillance
Non-industry stakeholders criticized the medical device user fee agreement for not giving FDA enough funding, particularly to enhance post-market surveillance programs, during an FDA public meeting on user fee reauthorization.
HELP Committee Leaders Aim To Prevent Controversial Add-Ons To User Fee Bill
Members of the Senate HELP Committee expressed concerns that potential riders added to the FDA user fee bill could slow down passage and add more work for FDA staff.